Dengue virus infected patients can generate false positives in the ‘gold standard’ Leptospira spp. microscopic agglutination test (MAT) and IgG- and IgM- antibody specific immunofluorescence and protein (Western) immunoblot assays due to cross-reactions with their outer surface membrane proteins: Public health concern
Claudia M. Romero-Vivas, Lissette Hernández Arrieta, Margarett Cuello-Pérez, Andrew K. Falconar
{"title":"Dengue virus infected patients can generate false positives in the ‘gold standard’ Leptospira spp. microscopic agglutination test (MAT) and IgG- and IgM- antibody specific immunofluorescence and protein (Western) immunoblot assays due to cross-reactions with their outer surface membrane proteins: Public health concern","authors":"Claudia M. Romero-Vivas, Lissette Hernández Arrieta, Margarett Cuello-Pérez, Andrew K. Falconar","doi":"10.1016/j.jiph.2025.102975","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The dengue viruses (DENVs) and <em>Leptospira</em> spp. both cause large numbers of human infections and fatalities within their widely overlapping distributions, thereby requiring differential diagnoses for appropriate patient therapies.</div></div><div><h3>Methods</h3><div>Many paired acute (S1) and convalescent (S2) phase patients’ sera were tested as potential on-going DENV infections by their IgM and/or IgG antibody reactions and DENV isolations and serotype determinations. The sera from these DENV-confirmed cases were further tested for their abilities to cross-react with the <em>Leptospira</em> spp. of different serovars in the ‘gold standard’ microscopic agglutination test (MAT), immunofluorescence assays (IFAs), IgM-ELISA and protein (Western) immunoblot assays, as well as <em>Leptospira</em> spp. isolation and PCR tests.</div></div><div><h3>Results</h3><div>In this study, 35 % of these patients’ sera were confirmed as on-going DENV infections by their dramatically (>> 4-fold S1 to S2) increased anti-DENV IgM and/or IgG antibody ELISA titres. Of those, 8.6 % also displayed high S2 and/or ≥ 4-fold increased S1 to S2 serum titres using the <em>Leptospira</em> spp. MAT due to their IgM and/or IgG cross-reactions with their 68–72, 38–42 and 18–22 kDa outer surface membrane proteins (OSMPs) identified by SDS-PAGE and protein (Western) blotting after Triton X-114 detergent phase-separations. DENV-1, −2 or −3 serotypes, but not <em>Leptospira</em> spp., were isolated and their sera were negative using a <em>Leptospira</em> spp.-specific PCR and commercial anti-<em>Leptospira</em> spp. IgM-specific ELISA.</div></div><div><h3>Conclusions</h3><div>This is the first report of false-positive anti-<em>Leptospira</em> spp. IgM and/or IgG antibody reactions resulting from on-going primary or secondary DENV infections which may: a) account for some ‘DENV-<em>Leptospira</em> spp. co-infections’ being erroneously reported and b) lead to inappropriate antibiotic therapies, rather than appropriate early supportive therapy for ‘severe dengue’ cases in their widely co-endemic pan-global regions.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"18 12","pages":"Article 102975"},"PeriodicalIF":4.0000,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Public Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1876034125003247","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The dengue viruses (DENVs) and Leptospira spp. both cause large numbers of human infections and fatalities within their widely overlapping distributions, thereby requiring differential diagnoses for appropriate patient therapies.
Methods
Many paired acute (S1) and convalescent (S2) phase patients’ sera were tested as potential on-going DENV infections by their IgM and/or IgG antibody reactions and DENV isolations and serotype determinations. The sera from these DENV-confirmed cases were further tested for their abilities to cross-react with the Leptospira spp. of different serovars in the ‘gold standard’ microscopic agglutination test (MAT), immunofluorescence assays (IFAs), IgM-ELISA and protein (Western) immunoblot assays, as well as Leptospira spp. isolation and PCR tests.
Results
In this study, 35 % of these patients’ sera were confirmed as on-going DENV infections by their dramatically (>> 4-fold S1 to S2) increased anti-DENV IgM and/or IgG antibody ELISA titres. Of those, 8.6 % also displayed high S2 and/or ≥ 4-fold increased S1 to S2 serum titres using the Leptospira spp. MAT due to their IgM and/or IgG cross-reactions with their 68–72, 38–42 and 18–22 kDa outer surface membrane proteins (OSMPs) identified by SDS-PAGE and protein (Western) blotting after Triton X-114 detergent phase-separations. DENV-1, −2 or −3 serotypes, but not Leptospira spp., were isolated and their sera were negative using a Leptospira spp.-specific PCR and commercial anti-Leptospira spp. IgM-specific ELISA.
Conclusions
This is the first report of false-positive anti-Leptospira spp. IgM and/or IgG antibody reactions resulting from on-going primary or secondary DENV infections which may: a) account for some ‘DENV-Leptospira spp. co-infections’ being erroneously reported and b) lead to inappropriate antibiotic therapies, rather than appropriate early supportive therapy for ‘severe dengue’ cases in their widely co-endemic pan-global regions.
期刊介绍:
The Journal of Infection and Public Health, first official journal of the Saudi Arabian Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and the Saudi Association for Public Health, aims to be the foremost scientific, peer-reviewed journal encompassing infection prevention and control, microbiology, infectious diseases, public health and the application of healthcare epidemiology to the evaluation of health outcomes. The point of view of the journal is that infection and public health are closely intertwined and that advances in one area will have positive consequences on the other.
The journal will be useful to all health professionals who are partners in the management of patients with communicable diseases, keeping them up to date. The journal is proud to have an international and diverse editorial board that will assist and facilitate the publication of articles that reflect a global view on infection control and public health, as well as emphasizing our focus on supporting the needs of public health practitioners.
It is our aim to improve healthcare by reducing risk of infection and related adverse outcomes by critical review, selection, and dissemination of new and relevant information in the field of infection control, public health and infectious diseases in all healthcare settings and the community.